ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Quantum Genomics

Quantum Genomics (ALQGC)

0.0721
0.00
(0.00%)
Closed November 30 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0721
Bid
0.07
Ask
0.0721
Volume
0.00
0.00 Day's Range 0.00
0.001 52 Week Range 0.1578
Market Cap
Previous Close
0.0721
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,592,874
Shares Outstanding
69,709,954
Dividend Yield
-
PE Ratio
-1.54
Earnings Per Share (EPS)
-0.05
Revenue
36k
Net Profit
-3.17M

About Quantum Genomics

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
-
Quantum Genomics is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALQGC. The last closing price for Quantum Genomics was 0.07 €. Over the last year, Quantum Genomics shares have traded in a share price range of 0.001 € to 0.1578 €.

Quantum Genomics currently has 69,709,954 shares outstanding. The market capitalization of Quantum Genomics is 5.03 € million. Quantum Genomics has a price to earnings ratio (PE ratio) of -1.54.

ALQGC Latest News

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Firibastat efficacy non-significant versus placeboThe REFRESH study and the development of firibastat in cardiology have been stoppedCash of 11 million euros allotted to the development of new...

Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share

PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension

PARIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medications...

Quantum Genomics announces the appointment of its new Scientific Advisory Board

PARIS, June 27, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

PARIS, May 09, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs

PARIS, May 04, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development of a new drug class directly...

Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update

PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€

Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat and explore new therapeutic fields based on the patented technology platform built around...

Quantum Genomics Raises a Gross Amount of Approximately € 15 M

Launch of capital increase of approximately €15 million for institutional investors with cancellation of the pre-emptive subscription rightA minimum of €12 million subscription commitments...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.07210.07210.072100DE
4000.07210.07210.072100DE
120.0633719.3181818180.00880.1380.008815928740.05280812DE
26-0.0389-35.0450450450.1110.1380.0017818250.05164118DE
52-0.0227-23.94514767930.09480.15780.0014468680.05836018DE
156-4.4659-98.41119435874.5384.5640.0013151840.50035824DE
260-2.9579-97.62046204623.036.1850.0013112211.80875906DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLCOTCoretech 5
0.0175 €
(75.00%)
11.13k
MLSRPSpeed Rabbit Pizza
6.30 €
(20.00%)
5
ALTDTonner Drones
0.0116 €
(18.37%)
45.26M
TRACTTeract SA
0.848 €
(18.11%)
123.46k
ALVALValbiotis SA
1.40 €
(18.04%)
613.41k
ALKALKALRAY SA
1.28 €
(-40.74%)
637.99k
ALNEVNeovacs
0.0002 €
(-33.33%)
16.21M
ALTAILighton
18.00 €
(-24.37%)
173.99k
MLLOILocasystem International
12.50 €
(-18.30%)
6
ALSAFSAFE
0.074 €
(-17.41%)
178.68k
ALTDTonner Drones
0.0116 €
(18.37%)
45.26M
BCPBanco Comercial Portugues SA
0.4478 €
(0.22%)
38.08M
ATOAtos SE
0.8972 €
(14.82%)
22.54M
ALHPIHopium SA
0.0089 €
(-2.20%)
19.27M
ALNEVNeovacs
0.0002 €
(-33.33%)
16.21M

Discussion

View Full Feed
shazam1355 shazam1355 3 minutes ago
Hi Jeunke,

I just checked on Fintel and the Institutional holdings are not showing 44 million but showing 40 million ......

Institutional Shares (Long) 40,321,520 - 32.95% (ex 13D/G) - change of 6.55MM shares 19.39% MRQ

https://fintel.io/so/us/lwlg
LWLG
zerosnoop zerosnoop 5 minutes ago
More of Sano's LIES exposed by AISI, well done

Because I said that the design of the AOT is to slow crude oil as it passes through the AOT for proper treatment you are now saying::

So Aot is now a bottle neck right after exiting a pump station’s 3500 hp turbulent outflo
QSEP
zerosnoop zerosnoop 6 minutes ago
So true. Thanks AISI for posting more FACTS & exposing the LIES of SHORTERS & BASHERS who continue to make fools of themselves

I have addressed all of the nonsense in your next to the last post many times in the past. I'm not going to waste my time again. I will leave you with one que
QSEP
rbtree rbtree 7 minutes ago
And yet, it remains at .0001---and below..... hope you are in some real companies....
KEGS
zerosnoop zerosnoop 8 minutes ago
More LIES exposed. Thanks to poster AISI for posting more FACTS. If the authorities don't believe the lying grubs with a low IQ, nor do I.

Sano sneers that "anyone following this company & awake knows it was a pressure hydrostatic test that they also ran a current through. It wasn't o
QSEP
uber darthium uber darthium 9 minutes ago
The update is written in a style and manner that could be described as matching your’s exactly.

Wow, what a freakish coincidence.

I guess that happens sometimes in this world. It’s just weird that the main cheerleader and defender of DBMM mirrors that of whomever is wr
DBMM
rbtree rbtree 9 minutes ago
That's great to hear. I'll email her again. I've shared some of my landscape, wildlife and astro imagery with her a couple time....
KEGS
zerosnoop zerosnoop 9 minutes ago
But poster AISI has exposed your lack of scientific and investment knowledge time & time again only for the compulsive liar & uneducated fool to run and hide.

You specifically claimed the most recent test was done without oil in the AOT. That was wrong! No amount of dancing and misdir
QSEP
Doc logic Doc logic 15 minutes ago
alphapuppy,

The crossover design also proved to be very beneficial on average for those who did, especially those who did not have a second resection. Regulators can be glad it was insisted upon by them even though it created issues for the trial data itself. Best wishes.
NWBO
johnnytrader33 johnnytrader33 15 minutes ago
But this is a proven SCAM over and over.
TSOI
ap17 ap17 17 minutes ago
Looks like it touched 3. Nice.
SHIBUSD
Konaploinks Konaploinks 18 minutes ago
Quantum Zoom message boards. That’s the ticket. IMO It won’t be long if Ionq has anything to say about it.
IONQ
arizona1 arizona1 18 minutes ago
Zuckerberg Seems Genuinely Alarmed by the Explosive Growth of Bluesky
Threads, X-formerly-Twitter: beware.

Bluesky has apparently become such a successful X-formerly-Twitter alternative that even Mark Zuckerberg is anxiously taking notice. At this rate, the social site could po
blackhawks blackhawks 19 minutes ago
Trump Names El Chapo Ambassador to Mexico
Nov 30, 2024

https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9fe7c25a-8e90-4a2f-b3ef-58464ed20393_441x418.jpeg
blackhawks blackhawks 21 minutes ago
Trump Names El Chapo Ambassador to Mexico
Nov 30, 2024

https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9fe7c25a-8e90-4a2f-b3ef-58464ed20393_441x418.jpeg
IHuser IHuser 21 minutes ago
imo... Vex....in these modern times....if you can not get through the scrutiny of ihub where retail can speak also....and your stock price can not puncture through the scrutiny of the retail market....you just cease to have a stock PFE...worth more than $1 pps... AND BK PROCEEDINGS PENDING.
PFE
blackhawks blackhawks 21 minutes ago
Trump Names El Chapo Ambassador to Mexico
Nov 30, 2024

https://substackcdn.com/image/fetch/w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9fe7c25a-8e90-4a2f-b3ef-58464ed20393_441x418.jpeg
Humbert Humbert 21 minutes ago
BNCM is now Delex.
BNCM
jfkspire jfkspire 21 minutes ago
They have not Filed yet, so I'm just curious how you see that the shares are restricted!!
Thanks in advance!!
TRCC
georgejjl georgejjl 21 minutes ago
Expect that the dosing of all patients in the Anavex 3-71 Phase 2 schizophrenia trial will probably have already been completed or soon will be completed and expect topline results soon.

https://www.anavex.com/post/anavex-life-sciences-announces-encouraging-preliminary-biomarker-resul
BMY
sylvia07 sylvia07 22 minutes ago
Full stream ahead...dbmm
DBMM
blackhawks blackhawks 22 minutes ago
There is no credible evidence that vaxxes in general, and Covid vaxes in particular, are not safe and effective.

Keep on falling for junk science articles, almost of which equate association with causation, and all of which have been repeatedly debunked because real peer reviewed scie
ipiros ipiros 23 minutes ago
https://www.instagram.com/p/DC9JHGKICMs/?igsh=cHhmemdidGlwbzY1


When is IGEX picking up the other 24 percent of this company? Come on Antonio follow through with the promises. 
IGEX
TightCoil TightCoil 24 minutes ago
Fannie Mae and Freddie Mac
Hello My Friends, lets try not to word our posts
in a way that would scare newbies from loadin'.
Newbies: Get Some - No Fear Here
FNMA

Your Recent History

Delayed Upgrade Clock